Form D · Biotechnology
Intellisafe LLC
Denver, CO · CIK 0001854636
Offering snapshot reported Mar 21, 2022 · SEC filing
- Reported sold
- $650K Offering amount: $1M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 10, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$205,000 → $650,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2022 | Amendment | $650,000 | $445,000vs Apr 12, 2021 | 18 | SEC filing |
| Apr 12, 2021 | Initial | $205,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-395456
Source: Form D, filed Mar 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Trevor Chandler | Director, Executive, Promoter |
| Adam Pener | Director, Executive, Promoter |
| Randy Roberts | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1550 Larimer Street Suite 634
Denver, CO, 80202
Denver, CO, 80202